Federated Hermes’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-28,582
| Closed | -$104K | – | 2346 |
|
|
2021
Q4 | $104K | Buy |
+28,582
| New | +$104K | ﹤0.01% | 1705 |
|
|
2018
Q3 | – | Sell |
-6
| Closed | -$1K | – | 2342 |
|
|
2018
Q2 | $1K | Sell |
6
-10
| -63% | -$1.67K | ﹤0.01% | 2163 |
|
|
2018
Q1 | $2K | Buy |
+16
| New | +$2K | ﹤0.01% | 2072 |
|
|
2017
Q1 | – | Sell |
-3,143
| Closed | -$398K | – | 2188 |
|
|
2016
Q4 | $398K | Hold |
3,143
| – | – | ﹤0.01% | 1365 |
|
|
2016
Q3 | $481K | Buy |
3,143
+1,238
| +65% | +$189K | ﹤0.01% | 1299 |
|
|
2016
Q2 | $219K | Hold |
1,905
| – | – | ﹤0.01% | 1471 |
|
|
2016
Q1 | $216K | Hold |
1,905
| – | – | ﹤0.01% | 1478 |
|
|
2015
Q4 | $359K | Hold |
1,905
| – | – | ﹤0.01% | 1374 |
|
|
2015
Q3 | $324K | Hold |
1,905
| – | – | ﹤0.01% | 1400 |
|
|
2015
Q2 | $1.2M | Buy |
1,905
+476
| +33% | +$301K | ﹤0.01% | 1092 |
|
|
2015
Q1 | $735K | Buy |
1,429
+477
| +50% | +$245K | ﹤0.01% | 1264 |
|
|
2014
Q4 | $510K | Sell |
952
-148
| -13% | -$79.3K | ﹤0.01% | 1345 |
|
|
2014
Q3 | $1.65M | Sell |
1,100
-380
| -26% | -$570K | 0.01% | 1035 |
|
|
2014
Q2 | $2.03M | Sell |
1,480
-782
| -35% | -$1.07M | 0.01% | 944 |
|
|
2014
Q1 | $3.14M | Buy |
+2,262
| New | +$3.14M | 0.01% | 787 |
|